Brand Name Preemption: The New Frontier In Pharmaceutical Product Liability Litigation

Food and Drug Law Journal | Volume 72 | Number 4

Brand Name Preemption: The New Frontier In Pharmaceutical Product Liability Litigation2021-04-21T16:10:23-04:00

Getting by with a Little Help from Their Friends: FDA Using External Experts to Enhance Biomarker Qualification and Enable Precision

Food and Drug Law Journal | Volume 72 | Number 4

Getting by with a Little Help from Their Friends: FDA Using External Experts to Enhance Biomarker Qualification and Enable Precision2021-04-21T16:16:01-04:00

Remarks by Acting FDA Commissioner Stephen M. Ostroff, MD (Open Access)

Food and Drug Law Journal | Volume 72 | Number 3

Remarks by Acting FDA Commissioner Stephen M. Ostroff, MD (Open Access)2021-07-22T15:48:12-04:00

The Role of Patient Participation in Drug Approvals: Lessons from the Accelerated Approval of Eteplirsen (Open Access)

Food and Drug Law Journal | Volume 72 | Number 3

The Role of Patient Participation in Drug Approvals: Lessons from the Accelerated Approval of Eteplirsen (Open Access)2021-07-22T15:48:22-04:00

Assessing the Scientific Basis of the Agricultural Water Provision of the FSMA Produce Safety Rule

Food and Drug Law Journal | Volume 72 | Number 3

Assessing the Scientific Basis of the Agricultural Water Provision of the FSMA Produce Safety Rule2021-04-22T16:09:02-04:00

Making the Case for a National Food Strategy in the United States (Open Access)

Food and Drug Law Journal | Volume 72 | Number 2

Making the Case for a National Food Strategy in the United States (Open Access)2021-07-22T15:48:34-04:00
Go to Top